Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-platelet Therapy”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT03304977
What this trial is testing

Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)

Who this might be right for
Coagulation Disorder
Fondation Hôpital Saint-Joseph 100
Very early researchStudy completedNCT04822363
What this trial is testing

The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry

Who this might be right for
Platelet Activation Testing Before/After Anti-platelet TherapyHealthy
Beth Israel Deaconess Medical Center 112
Post-approval studies (Phase 4)Study completedNCT01659034
What this trial is testing

Short and Optimal Duration of Dual Antiplatelet Therapy Study

Who this might be right for
Coronary Artery Disease
Takeshi Morimoto 1,525
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Not applicableEnded earlyNCT04885816
What this trial is testing

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty

Who this might be right for
High Bleeding RiskCoronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)
Instituto Nacional de Cardiologia Ignacio Chavez 5
Not applicableStudy completedNCT02508116
What this trial is testing

Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention

Who this might be right for
Acute Coronary SyndromeCardiovascular Diseases
University of Pennsylvania 509
Large-scale testing (Phase 3)Study completedNCT00269906
What this trial is testing

A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty

Who this might be right for
Angina, UnstableAngioplasty, Transluminal, Percutaneous Coronary
Centocor, Inc. 1,265
Testing effectiveness (Phase 2)Active Not RecruitingNCT06199089
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 45
Large-scale testing (Phase 3)UnknownNCT01385319
What this trial is testing

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

Who this might be right for
Coronary Artery Disease
Marco Valgimigli 1,606
Not applicableStudy completedNCT01477528
What this trial is testing

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

Who this might be right for
AnticoagulationLeft Ventricular Assist Device
Abbott Medical Devices 201
Early research (Phase 1)Study completedNCT03245489
What this trial is testing

Anti-platelet + Pembro for H&N Tumors

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 20
Testing effectiveness (Phase 2)Looking for participantsNCT07297563
What this trial is testing

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Not applicableNot Yet RecruitingNCT07140133
What this trial is testing

Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

Who this might be right for
High Bleeding Risk PatientsCardiologyStent Implantation+1 more
University Hospital, Grenoble 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT06838962
What this trial is testing

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Post-approval studies (Phase 4)UnknownNCT03182855
What this trial is testing

Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionSTEMI - ST Elevation Myocardial Infarction
University of Aarhus 80
Not applicableStudy completedNCT00465218
What this trial is testing

Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

Who this might be right for
Aortic Valve Disease
Ottawa Heart Institute Research Corporation 70
Not applicableStudy completedNCT01134679
What this trial is testing

(EASY)-IMProving Adherence to Clopidogrel Trial (IMPACT))

Who this might be right for
Coronary Artery Disease
Laval University 300
Large-scale testing (Phase 3)Study completedNCT02506140
What this trial is testing

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeIschemic Attack, Transient
Beijing Tiantan Hospital 675
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Next Page